img

Global Oral Antiviral Medicines for COVID-19 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Oral Antiviral Medicines for COVID-19 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Oral Antiviral Medicines for COVID-19 report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Oral Antiviral Medicines for COVID-19 market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Aldult and Elder are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Antiviral Medicines for COVID-19 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Oral Antiviral Medicines for COVID-19 key manufacturers include Pfizer, Merck, Shionogi, Simcere Pharmaceutical, Frontier Biotechnologies and Kexing Biopharm, etc. Pfizer, Merck, Shionogi are top 3 players and held % sales share in total in 2023.
Oral Antiviral Medicines for COVID-19 can be divided into Lagevrio, Paxlovid and Azvudine,, etc. Lagevrio is the mainstream product in the market, accounting for % sales share globally in 2023.
Oral Antiviral Medicines for COVID-19 is widely used in various fields, such as Aldult and Elder, etc. Aldult provides greatest supports to the Oral Antiviral Medicines for COVID-19 industry development. In 2023, global % sales of Oral Antiviral Medicines for COVID-19 went into Aldult filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Oral Antiviral Medicines for COVID-19 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Merck
Shionogi
Simcere Pharmaceutical
Frontier Biotechnologies
Kexing Biopharm
Segment by Type
Lagevrio
Paxlovid
Azvudine

Segment by Application


Aldult
Elder

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Antiviral Medicines for COVID-19 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Antiviral Medicines for COVID-19, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Antiviral Medicines for COVID-19 industry.
Chapter 3Historical (2018-2023) and forecast (2023-2033) volume and revenue analysis of Oral Antiviral Medicines for COVID-19 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Antiviral Medicines for COVID-19 introduction, etc. Oral Antiviral Medicines for COVID-19 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRA Research’s Conclusions of Oral Antiviral Medicines for COVID-19 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRA Research.

Table of Content

1 Oral Antiviral Medicines for COVID-19 Market Overview
1.1 Oral Antiviral Medicines for COVID-19 Product Overview
1.2 Oral Antiviral Medicines for COVID-19 Market Segment by Type
1.2.1 Lagevrio
1.2.2 Paxlovid
1.2.3 Azvudine
1.3 Global Oral Antiviral Medicines for COVID-19 Market Size by Type
1.3.1 Global Oral Antiviral Medicines for COVID-19 Market Size Overview by Type (2018-2033)
1.3.2 Global Oral Antiviral Medicines for COVID-19 Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oral Antiviral Medicines for COVID-19 Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Antiviral Medicines for COVID-19 Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oral Antiviral Medicines for COVID-19 Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oral Antiviral Medicines for COVID-19 Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales Breakdown by Type (2018-2023)
2 Global Oral Antiviral Medicines for COVID-19 Market Competition by Company
2.1 Global Top Players by Oral Antiviral Medicines for COVID-19 Sales (2018-2023)
2.2 Global Top Players by Oral Antiviral Medicines for COVID-19 Revenue (2018-2023)
2.3 Global Top Players by Oral Antiviral Medicines for COVID-19 Price (2018-2023)
2.4 Global Top Manufacturers Oral Antiviral Medicines for COVID-19 Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Antiviral Medicines for COVID-19 Market Competitive Situation and Trends
2.5.1 Oral Antiviral Medicines for COVID-19 Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Antiviral Medicines for COVID-19 Sales and Revenue in 2023
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Antiviral Medicines for COVID-19 as of 2023)
2.7 Date of Key Manufacturers Enter into Oral Antiviral Medicines for COVID-19 Market
2.8 Key Manufacturers Oral Antiviral Medicines for COVID-19 Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Antiviral Medicines for COVID-19 Status and Outlook by Region
3.1 Global Oral Antiviral Medicines for COVID-19 Market Size and CAGR by Region: 2018 VS 2023 VS 2033
3.2 Global Oral Antiviral Medicines for COVID-19 Historic Market Size by Region
3.2.1 Global Oral Antiviral Medicines for COVID-19 Sales in Volume by Region (2018-2023)
3.2.2 Global Oral Antiviral Medicines for COVID-19 Sales in Value by Region (2018-2023)
3.2.3 Global Oral Antiviral Medicines for COVID-19 Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oral Antiviral Medicines for COVID-19 Forecasted Market Size by Region
3.3.1 Global Oral Antiviral Medicines for COVID-19 Sales in Volume by Region (2024-2033)
3.3.2 Global Oral Antiviral Medicines for COVID-19 Sales in Value by Region (2024-2033)
3.3.3 Global Oral Antiviral Medicines for COVID-19 Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global Oral Antiviral Medicines for COVID-19 by Application
4.1 Oral Antiviral Medicines for COVID-19 Market Segment by Application
4.1.1 Aldult
4.1.2 Elder
4.2 Global Oral Antiviral Medicines for COVID-19 Market Size by Application
4.2.1 Global Oral Antiviral Medicines for COVID-19 Market Size Overview by Application (2018-2033)
4.2.2 Global Oral Antiviral Medicines for COVID-19 Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oral Antiviral Medicines for COVID-19 Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Antiviral Medicines for COVID-19 Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oral Antiviral Medicines for COVID-19 Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oral Antiviral Medicines for COVID-19 Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales Breakdown by Application (2018-2023)
5 North America Oral Antiviral Medicines for COVID-19 by Country
5.1 North America Oral Antiviral Medicines for COVID-19 Historic Market Size by Country
5.1.1 North America Oral Antiviral Medicines for COVID-19 Market Size Growth Rate (CAGR) by Country: 2018 VS 2023 VS 2033
5.1.2 North America Oral Antiviral Medicines for COVID-19 Sales in Volume by Country (2018-2023)
5.1.3 North America Oral Antiviral Medicines for COVID-19 Sales in Value by Country (2018-2023)
5.2 North America Oral Antiviral Medicines for COVID-19 Forecasted Market Size by Country
5.2.1 North America Oral Antiviral Medicines for COVID-19 Sales in Volume by Country (2024-2033)
5.2.2 North America Oral Antiviral Medicines for COVID-19 Sales in Value by Country (2024-2033)
6 Europe Oral Antiviral Medicines for COVID-19 by Country
6.1 Europe Oral Antiviral Medicines for COVID-19 Historic Market Size by Country
6.1.1 Europe Oral Antiviral Medicines for COVID-19 Market Size Growth Rate (CAGR) by Country: 2018 VS 2023 VS 2033
6.1.2 Europe Oral Antiviral Medicines for COVID-19 Sales in Volume by Country (2018-2023)
6.1.3 Europe Oral Antiviral Medicines for COVID-19 Sales in Value by Country (2018-2023)
6.2 Europe Oral Antiviral Medicines for COVID-19 Forecasted Market Size by Country
6.2.1 Europe Oral Antiviral Medicines for COVID-19 Sales in Volume by Country (2024-2033)
6.2.2 Europe Oral Antiviral Medicines for COVID-19 Sales in Value by Country (2024-2033)
7 Asia-Pacific Oral Antiviral Medicines for COVID-19 by Region
7.1 Asia-Pacific Oral Antiviral Medicines for COVID-19 Historic Market Size by Region
7.1.1 Asia-Pacific Oral Antiviral Medicines for COVID-19 Market Size Growth Rate (CAGR) by Region: 2018 VS 2023 VS 2033
7.1.2 Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oral Antiviral Medicines for COVID-19 Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales in Value by Region (2024-2033)
8 Latin America Oral Antiviral Medicines for COVID-19 by Country
8.1 Latin America Oral Antiviral Medicines for COVID-19 Historic Market Size by Country
8.1.1 Latin America Oral Antiviral Medicines for COVID-19 Market Size Growth Rate (CAGR) by Country: 2018 VS 2023 VS 2033
8.1.2 Latin America Oral Antiviral Medicines for COVID-19 Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oral Antiviral Medicines for COVID-19 Sales in Value by Country (2018-2023)
8.2 Latin America Oral Antiviral Medicines for COVID-19 Forecasted Market Size by Country
8.2.1 Latin America Oral Antiviral Medicines for COVID-19 Sales in Volume by Country (2024-2033)
8.2.2 Latin America Oral Antiviral Medicines for COVID-19 Sales in Value by Country (2024-2033)
9 Middle East and Africa Oral Antiviral Medicines for COVID-19 by Country
9.1 Middle East and Africa Oral Antiviral Medicines for COVID-19 Historic Market Size by Country
9.1.1 Middle East and Africa Oral Antiviral Medicines for COVID-19 Market Size Growth Rate (CAGR) by Country: 2018 VS 2023 VS 2033
9.1.2 Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oral Antiviral Medicines for COVID-19 Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Oral Antiviral Medicines for COVID-19 Products Offered
10.1.5 Pfizer Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Oral Antiviral Medicines for COVID-19 Products Offered
10.2.5 Merck Recent Development
10.3 Shionogi
10.3.1 Shionogi Company Information
10.3.2 Shionogi Introduction and Business Overview
10.3.3 Shionogi Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Shionogi Oral Antiviral Medicines for COVID-19 Products Offered
10.3.5 Shionogi Recent Development
10.4 Simcere Pharmaceutical
10.4.1 Simcere Pharmaceutical Company Information
10.4.2 Simcere Pharmaceutical Introduction and Business Overview
10.4.3 Simcere Pharmaceutical Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Simcere Pharmaceutical Oral Antiviral Medicines for COVID-19 Products Offered
10.4.5 Simcere Pharmaceutical Recent Development
10.5 Frontier Biotechnologies
10.5.1 Frontier Biotechnologies Company Information
10.5.2 Frontier Biotechnologies Introduction and Business Overview
10.5.3 Frontier Biotechnologies Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Frontier Biotechnologies Oral Antiviral Medicines for COVID-19 Products Offered
10.5.5 Frontier Biotechnologies Recent Development
10.6 Kexing Biopharm
10.6.1 Kexing Biopharm Company Information
10.6.2 Kexing Biopharm Introduction and Business Overview
10.6.3 Kexing Biopharm Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Kexing Biopharm Oral Antiviral Medicines for COVID-19 Products Offered
10.6.5 Kexing Biopharm Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Antiviral Medicines for COVID-19 Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Antiviral Medicines for COVID-19 Industrial Chain Analysis
11.4 Oral Antiviral Medicines for COVID-19 Market Dynamics
11.4.1 Oral Antiviral Medicines for COVID-19 Industry Trends
11.4.2 Oral Antiviral Medicines for COVID-19 Market Drivers
11.4.3 Oral Antiviral Medicines for COVID-19 Market Challenges
11.4.4 Oral Antiviral Medicines for COVID-19 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Antiviral Medicines for COVID-19 Distributors
12.3 Oral Antiviral Medicines for COVID-19 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Lagevrio
Table 2. Major Company of Paxlovid
Table 3. Major Company of Azvudine
Table 4. Global Oral Antiviral Medicines for COVID-19 Sales by Type 2018 VS 2023 VS 2033 (US$ Million)
Table 5. Global Oral Antiviral Medicines for COVID-19 Sales by Type (2018-2023) & (Units)
Table 6. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Type (2018-2023)
Table 7. Global Oral Antiviral Medicines for COVID-19 Sales by Type (2018-2023) & (US& Million)
Table 8. Global Oral Antiviral Medicines for COVID-19 Market Share in Value by Type (2018-2023)
Table 9. Global Oral Antiviral Medicines for COVID-19 Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Oral Antiviral Medicines for COVID-19 Sales by Type (2024-2033) & (Units)
Table 11. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Type (2024-2033)
Table 12. Global Oral Antiviral Medicines for COVID-19 Sales by Type (2024-2033) & (US$ Million)
Table 13. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Type (2024-2033)
Table 14. Global Oral Antiviral Medicines for COVID-19 Price by Type (2024-2033) & (US$/Unit)
Table 15. North America Oral Antiviral Medicines for COVID-19 Sales by Type (2018-2023) & (Units)
Table 16. North America Oral Antiviral Medicines for COVID-19 Sales by Type (2018-2023) & (US$ Million)
Table 17. Europe Oral Antiviral Medicines for COVID-19 Sales (Units) by Type (2018-2023)
Table 18. Europe Oral Antiviral Medicines for COVID-19 Sales by Type (2018-2023) & (US$ Million)
Table 19. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales (Units) by Type (2018-2023)
Table 20. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales by Type (2018-2023) & (US$ Million)
Table 21. Latin America Oral Antiviral Medicines for COVID-19 Sales (Units) by Type (2018-2023)
Table 22. Latin America Oral Antiviral Medicines for COVID-19 Sales by Type (2018-2023) & (US$ Million)
Table 23. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales (Units) by Type (2018-2023)
Table 24. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales by Type (2018-2023) & (US$ Million)
Table 25. Global Oral Antiviral Medicines for COVID-19 Sales by Company (2018-2023) & (Units)
Table 26. Global Oral Antiviral Medicines for COVID-19 Sales Share by Company (2018-2023)
Table 27. Global Oral Antiviral Medicines for COVID-19 Revenue by Company (2018-2023) & (US$ Million)
Table 28. Global Oral Antiviral Medicines for COVID-19 Revenue Share by Company (2018-2023)
Table 29. Global Market Oral Antiviral Medicines for COVID-19 Price by Company (2018-2023) & (US$/Unit)
Table 30. Global Oral Antiviral Medicines for COVID-19 Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Oral Antiviral Medicines for COVID-19 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Antiviral Medicines for COVID-19 as of 2023)
Table 33. Date of Key Manufacturers Enter into Oral Antiviral Medicines for COVID-19 Market
Table 34. Key Manufacturers Oral Antiviral Medicines for COVID-19 Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Oral Antiviral Medicines for COVID-19 Market Size Comparison by Region (US$ Million): 2018 VS 2023 VS 2033
Table 37. Global Oral Antiviral Medicines for COVID-19 Sales by Region (2018-2023) & (Units)
Table 38. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Region (2018-2023)
Table 39. Global Oral Antiviral Medicines for COVID-19 Sales by Region (2018-2023) & (US$ Million)
Table 40. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Region (2018-2023)
Table 41. Global Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 42. Global Oral Antiviral Medicines for COVID-19 Sales by Region (2024-2033) & (Units)
Table 43. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Region (2024-2033)
Table 44. Global Oral Antiviral Medicines for COVID-19 Sales by Region (2024-2033) & (US$ Million)
Table 45. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Region (2024-2033)
Table 46. Global Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2033)
Table 47. Global Oral Antiviral Medicines for COVID-19 Sales by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 48. Global Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) & (Units)
Table 49. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Application (2018-2023)
Table 50. Global Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) & (US$ Million)
Table 51. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Application (2018-2023)
Table 52. Global Oral Antiviral Medicines for COVID-19 Price by Application (2018-2023) & (US$/Unit)
Table 53. Global Oral Antiviral Medicines for COVID-19 Sales by Application (2024-2033) & (Units)
Table 54. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Application (2024-2033)
Table 55. Global Oral Antiviral Medicines for COVID-19 Sales by Application (2024-2033) & (US$ Million)
Table 56. Global Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Application (2024-2033)
Table 57. Global Oral Antiviral Medicines for COVID-19 Price by Application (2024-2033) & (US$/Unit)
Table 58. North America Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) (Units)
Table 59. North America Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) & (US$ Million)
Table 60. Europe Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) (Units)
Table 61. Europe Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) & (US$ Million)
Table 62. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) (Units)
Table 63. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) & (US$ Million)
Table 64. Latin America Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) (Units)
Table 65. Latin America Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) (Units)
Table 67. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2023) & (US$ Million)
Table 68. North America Oral Antiviral Medicines for COVID-19 Sales by Country (2018-2023) & (Units)
Table 69. North America Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Country (2018-2023)
Table 70. North America Oral Antiviral Medicines for COVID-19 Sales by Country (2018-2023) & (US$ Million)
Table 71. North America Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Country (2018-2023)
Table 72. North America Oral Antiviral Medicines for COVID-19 Sales by Country (2024-2033) & (Units)
Table 73. North America Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Country (2024-2033)
Table 74. North America Oral Antiviral Medicines for COVID-19 Sales by Country (2024-2033) & (US$ Million)
Table 75. North America Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Country (2024-2033)
Table 76. Europe Oral Antiviral Medicines for COVID-19 Sales by Country (2018-2023) & (Units)
Table 77. Europe Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Country (2018-2023)
Table 78. Europe Oral Antiviral Medicines for COVID-19 Sales by Country (2018-2023) & (US$ Million)
Table 79. Europe Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Country (2018-2023)
Table 80. Europe Oral Antiviral Medicines for COVID-19 Sales by Country (2024-2033) & (Units)
Table 81. Europe Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Country (2024-2033)
Table 82. Europe Oral Antiviral Medicines for COVID-19 Sales by Country (2024-2033) & (US$ Million)
Table 83. Europe Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Country (2024-2033)
Table 84. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales by Region (2018-2023) & (Units)
Table 85. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Region (2018-2023)
Table 86. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales by Region (2018-2023) & (US$ Million)
Table 87. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Region (2018-2023)
Table 88. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales by Region (2024-2033) & (Units)
Table 89. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Region (2024-2033)
Table 90. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales by Region (2024-2033) & (US$ Million)
Table 91. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Region (2024-2033)
Table 92. Latin America Oral Antiviral Medicines for COVID-19 Sales by Country (2018-2023) & (Units)
Table 93. Latin America Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Country (2018-2023)
Table 94. Latin America Oral Antiviral Medicines for COVID-19 Sales by Country (2018-2023) & (US$ Million)
Table 95. Latin America Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Country (2018-2023)
Table 96. Latin America Oral Antiviral Medicines for COVID-19 Sales by Country (2024-2033) & (Units)
Table 97. Latin America Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Country (2024-2033)
Table 98. Latin America Oral Antiviral Medicines for COVID-19 Sales by Country (2024-2033) & (US$ Million)
Table 99. Latin America Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Country (2024-2033)
Table 100. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales by Country (2018-2023) & (Units)
Table 101. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Country (2018-2023)
Table 102. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales by Country (2018-2023) & (US$ Million)
Table 103. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Country (2018-2023)
Table 104. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales by Country (2024-2033) & (Units)
Table 105. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Country (2024-2033)
Table 106. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales by Country (2024-2033) & (US$ Million)
Table 107. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Country (2024-2033)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Pfizer Oral Antiviral Medicines for COVID-19 Product
Table 112. Pfizer Recent Development
Table 113. Merck Company Information
Table 114. Merck Introduction and Business Overview
Table 115. Merck Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Merck Oral Antiviral Medicines for COVID-19 Product
Table 117. Merck Recent Development
Table 118. Shionogi Company Information
Table 119. Shionogi Introduction and Business Overview
Table 120. Shionogi Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Shionogi Oral Antiviral Medicines for COVID-19 Product
Table 122. Shionogi Recent Development
Table 123. Simcere Pharmaceutical Company Information
Table 124. Simcere Pharmaceutical Introduction and Business Overview
Table 125. Simcere Pharmaceutical Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Simcere Pharmaceutical Oral Antiviral Medicines for COVID-19 Product
Table 127. Simcere Pharmaceutical Recent Development
Table 128. Frontier Biotechnologies Company Information
Table 129. Frontier Biotechnologies Introduction and Business Overview
Table 130. Frontier Biotechnologies Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Frontier Biotechnologies Oral Antiviral Medicines for COVID-19 Product
Table 132. Frontier Biotechnologies Recent Development
Table 133. Kexing Biopharm Company Information
Table 134. Kexing Biopharm Introduction and Business Overview
Table 135. Kexing Biopharm Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Kexing Biopharm Oral Antiviral Medicines for COVID-19 Product
Table 137. Kexing Biopharm Recent Development
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Oral Antiviral Medicines for COVID-19 Market Trends
Table 141. Oral Antiviral Medicines for COVID-19 Market Drivers
Table 142. Oral Antiviral Medicines for COVID-19 Market Challenges
Table 143. Oral Antiviral Medicines for COVID-19 Market Restraints
Table 144. Oral Antiviral Medicines for COVID-19 Distributors List
Table 145. Oral Antiviral Medicines for COVID-19 Downstream Customers
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Antiviral Medicines for COVID-19 Product Picture
Figure 2. Global Oral Antiviral Medicines for COVID-19 Market Size, 2018 VS 2023 VS 2033 (US$ Million)
Figure 3. Global Oral Antiviral Medicines for COVID-19 Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global Oral Antiviral Medicines for COVID-19 Sales Status and Outlook (2018-2033) & (Units)
Figure 5. Product Picture of Lagevrio
Figure 6. Global Lagevrio Sales YoY Growth (2018-2033) & (Units)
Figure 7. Product Picture of Paxlovid
Figure 8. Global Paxlovid Sales YoY Growth (2018-2033) & (Units)
Figure 9. Product Picture of Azvudine
Figure 10. Global Azvudine Sales YoY Growth (2018-2033) & (Units)
Figure 11. Global Oral Antiviral Medicines for COVID-19 Sales by Type (2018-2033) & (US$ Million)
Figure 12. Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Type in 2023 & 2033
Figure 13. North America Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Type in 2023
Figure 14. North America Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Type in 2023
Figure 15. Europe Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Type in 2023
Figure 16. Europe Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Type in 2023
Figure 17. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Type in 2023
Figure 18. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Type in 2023
Figure 19. Latin America Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Type in 2023
Figure 20. Latin America Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Type in 2023
Figure 21. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Type in 2023
Figure 22. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Type in 2023
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Antiviral Medicines for COVID-19 Sales in 2023
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Antiviral Medicines for COVID-19 Revenue in 2023
Figure 25. Oral Antiviral Medicines for COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2023
Figure 26. Product Picture of Aldult
Figure 27. Global Aldult Sales YoY Growth (2018-2033) & (Units)
Figure 28. Product Picture of Elder
Figure 29. Global Elder Sales YoY Growth (2018-2033) & (Units)
Figure 30. Global Oral Antiviral Medicines for COVID-19 Sales by Application (2018-2033) & (US$ Million)
Figure 31. Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Application in 2023 & 2033
Figure 32. North America Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Application in 2023
Figure 33. North America Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Application in 2023
Figure 34. Europe Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Application in 2023
Figure 35. Europe Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Application in 2023
Figure 36. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Application in 2023
Figure 37. Asia-Pacific Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Application in 2023
Figure 38. Latin America Oral Antiviral Medicines for COVID-19 Sales Market Share in Volume by Application in 2023
Figure 39. Latin America Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Application in 2023
Figure 40. Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales Market Share in Value by Application in 2023
Figure 41. Key Raw Materials Price
Figure 42. Oral Antiviral Medicines for COVID-19 Manufacturing Cost Structure
Figure 43. Oral Antiviral Medicines for COVID-19 Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries